- Report
- July 2022
- 100 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Report
- July 2022
- 100 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Report
- July 2022
- 100 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €1565EUR$1,575USD£1,301GBP
€2235EUR$2,250USD£1,858GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €1565EUR$1,575USD£1,301GBP
€2235EUR$2,250USD£1,858GBP
- Drug Pipelines
- July 2022
- 60 Pages
Global
From €1565EUR$1,575USD£1,301GBP
€2235EUR$2,250USD£1,858GBP
- Report
- July 2022
- 100 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,271GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- April 2023
- 150 Pages
Global
From €4818EUR$4,850USD£4,006GBP
- Report
- September 2022
- 142 Pages
Asia Pacific
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- May 2024
- 85 Pages
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- May 2024
- 55 Pages
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- April 2024
- 61 Pages
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- January 2024
- 83 Pages
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- November 2023
- 150 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- November 2023
- 150 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- November 2023
- 137 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- November 2023
- 197 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
- Report
- October 2023
- 129 Pages
Europe
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- October 2023
- 133 Pages
North America
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
The Cardiovascular Devices market is a segment of the medical device industry that focuses on the diagnosis, treatment, and prevention of cardiovascular diseases. It includes a range of products such as pacemakers, stents, catheters, and other implantable devices. These devices are used to diagnose and treat conditions such as arrhythmia, heart failure, and coronary artery disease.
The market is driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. Additionally, the rising geriatric population and the increasing awareness of cardiovascular diseases are expected to drive the market growth.
Some of the major companies in the Cardiovascular Devices market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, St. Jude Medical, and Johnson & Johnson. Show Less Read more